| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.40B | +40.2% |
| Cost of Revenue | $1.50B | +29.7% |
| R&D Expense | $1.50B | +5.4% |
| SG&A Expense | $950.0M | +13.7% |
| Operating Income | $1.80B | +319.7% |
| Pre-tax Income | $1.99B | +762.5% |
| Income Tax | $96.0M | +85.2% |
| Net Income | $1.89B | +637.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.38B | +21.6% |
| Short-term Investments | $2.24B | -0.5% |
| Current Assets | $14.86B | +20.0% |
| Total Assets | $16.04B | +17.0% |
| Current Liabilities | $7.98B | +25.5% |
| Long-term Debt | $1.99B | -0.7% |
| Total Liabilities | $10.48B | +17.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.43B | +56.6% |
| Capital Expenditures | $25.0M | -1.3% |
| Investing Cash Flow | -$28.0M | +97.9% |
| Financing Cash Flow | -$689.0M | -148.1% |
| Free Cash Flow | $3.40B | +57.3% |
| Stockholders' Equity |
| $5.56B |
| +16.4% |